Main Ingredient: Medical sodium hyaluronate, 14mg/ml content Properties: colorless, tasteless, transparent and viscous liquid, PH6.8~7.5 Pharmacological action The polysaccharide is composed of 1,4--linked disaccharides of D-glucuronosyl-1, 3-β-N-acetyl-D-glucosamine, which molecules in aqueous solution display marked stiffness and very limited configurational flexibility. There is much water in their spongy gap. When the molecules enlarge, the viscosity of the polysaccharide increase rapidly and with density raising, the elasticity of the solution increase correspondingly. Because of the possessing pseudoplasticity, it keeps stable shape in aqueous liquid and possesses the action of protecting cornea endothelium and is most idealest viscoelastic agent for ophthalmologic operation. Indication 1. Intra-/extra-capsular cataract extraction( Intraocular lens implantation) 2. Corneal transplantation 3. Glaucomatous operation 4. Retinal detachment 5. Phacoemulsification of cataract 6. Trabecul ectomy 7. Total iridectomy 8. Vitreous amputation 9. Eye injury and ophthalmic surgery Product content: 0.5ml/syringe tube, 0.8ml/syringe tube, 1.0ml/syringe tube. Storage: Be stored at 2℃~8℃,kept away from light, and no freezing. Package: One syringe per box Shelf period: Two years. Approval code number: SFDA Xie Zhun Zi 2006 No. 3640783